PURIST
LIVE

Serial Number

97979703

Owner

GENECENTRIC THERAPEUTICS, INC.

Attorney

Devon E. White

Filing Date

Dec 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PURIST Trademark

Serial Number: 97979703 • Registration: 7725072

PURIST is a trademark filed by GENECENTRIC THERAPEUTICS, INC. on December 22, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENECENTRIC THERAPEUTICS, INC. (12 trademarks)

4401 Research Commons, Suite 105
Research Triangle Park, NC 27709

Entity Type: 03

Trademark Details

Filing Date

December 22, 2022

Registration Date

March 11, 2025

Published for Opposition

April 9, 2024

Goods & Services

Medical testing services for diagnosis, prognosis, treatment, and management of cancer; Medical testing for diagnostic and treatment option purposes; Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer; Provision of health care services, namely, providing oncological testing reports to physicians

Providing medical and scientific research in the field of oncology, tumor biology, and diagnosis and treatment of cancers; Pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the field of oncology; Research and development in the field of RNA expression, namely, cancer biology; Research and development services for others, namely, research and development of assays for oncological testing and diagnostic purposes; Scientific research in the field of RNA expression analysis and reporting; Providing laboratory research services in the field of pancreatic cancer; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Pharmaceutical and medical research in the field of survival outcomes and standard of care research; Medical research featuring the identification and validation of cancer related biomarkers and RNA expression for use in improved patient outcomes; Providing a website and information in the field of medical research and scientific research in the fields of tumor biology, oncology, and diagnosis and treatment of cancers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 11, 2025 R.PR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 20, 2025 EXRA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 13, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 13, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 13, 2025 SUPC
SOU EXTENSION 1 GRANTED
Feb 13, 2025 EX1G
DIVISIONAL PROCESSING COMPLETE
Feb 13, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 10, 2024 AITU
USE AMENDMENT FILED
Oct 1, 2024 IUAF
SOU EXTENSION 1 FILED
Oct 1, 2024 EXT1
DIVISIONAL REQUEST RECEIVED
Oct 1, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Oct 1, 2024 ERTD
TEAS STATEMENT OF USE RECEIVED
Oct 1, 2024 EISU
SOU TEAS EXTENSION RECEIVED
Oct 1, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 19, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 19, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2023 NWOS
NEW APPLICATION ENTERED
Dec 26, 2022 NWAP